Sun Wei, Tang Ying, Tai Yi-Yin, Handen Adam, Zhao Jingsi, Speyer Gil, Al Aaraj Yassmin, Watson Annie, Romanelli Makenna E, Sembrat John, Rojas Mauricio, Simon Marc A, Zhang Yingze, Lee Janet, Xiong Zeyu, Dutta Partha, Vasamsetti Sathish Badu, McNamara Dennis, McVerry Bryan, McTiernan Charles F, Sciurba Frank C, Kim Seungchan, Smith Kerri Akaya, Mazurek Jeremy A, Han Yuchi, Vaidya Anjali, Nouraie Seyed Mehdi, Kelly Neil J, Chan Stephen Y
Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, Division of Cardiology and Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Research Computing, Arizona State University, Tempe, Arizona, USA.
JACC Basic Transl Sci. 2020 Nov 4;5(11):1073-1092. doi: 10.1016/j.jacbts.2020.08.010. eCollection 2020 Nov.
Utilizing publicly available ribonucleic acid sequencing data, we identified as a BMPR2-related gene differentially expressed between induced pluripotent stem cell-endothelial cells derived from pulmonary arterial hypertension (PAH) patients carrying pathogenic BMPR2 mutations and control patients without mutations. Endothelial SCUBE1 expression was decreased by known triggers of PAH, and its down-regulation recapitulated known BMPR2-associated endothelial pathophenotypes in vitro. Meanwhile, SCUBE1 concentrations were reduced in plasma obtained from PAH rodent models and patients with PAH, whereas plasma concentrations were tightly correlated with hemodynamic markers of disease severity. Taken together, these data implicate SCUBE1 as a novel contributor to PAH pathogenesis with potential therapeutic, diagnostic, and prognostic applications.
利用公开可用的核糖核酸测序数据,我们鉴定出一个与骨形态发生蛋白受体2(BMPR2)相关的基因,该基因在携带致病性BMPR2突变的肺动脉高压(PAH)患者来源的诱导多能干细胞-内皮细胞与无突变的对照患者之间差异表达。PAH的已知触发因素可降低内皮SCUBE1的表达,其下调在体外重现了已知的与BMPR2相关的内皮病理表型。同时,从PAH啮齿动物模型和PAH患者获得的血浆中SCUBE1浓度降低,而血浆浓度与疾病严重程度的血流动力学标志物密切相关。综上所述,这些数据表明SCUBE1是PAH发病机制的一个新因素,具有潜在的治疗、诊断和预后应用价值。